Apimeds Pharmaceuticals US APUS
NYSE APUS
$3.25 -0.25 (-7.14%)
As of: Oct 20, 2026 · 3:58 PM EDT

Apimeds Pharmaceuticals US (APUS) Non-Current Assets (2025 - 2026)

Updated

Apimeds Pharmaceuticals US (APUS) recorded Non-Current Assets of $116.95 million in Q2 2026, compared with $197,132 a year earlier.

Analysis

Apimeds Pharmaceuticals US (APUS) Non-Current Assets (2025 - 2026) Analysis & Trends

At the end of FY2025, Apimeds Pharmaceuticals US reported Non-Current Assets of $150.2 million.

  • Quarterly Non-Current Assets has ranged from $163,928 in Q3 2025 to $150.2 million in Q4 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 141.29 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 101.45 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 87.87 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 35.42 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 159.77 Bn
10 Apimeds Pharmaceuticals US 5.65 Mn -13.98 Mn - 116.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 116.95 Mn
Dec 31, 2025 150.20 Mn
Sep 30, 2025 163,928.00
Jun 30, 2025 197,132.00
API Access

Apimeds Pharmaceuticals US Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=APUS&period=max&api_key=YOUR_API_KEY